In a surprising move, the European Union’s General Court has annulled a massive €1.49 billion fine imposed on Google by the European Commission, sending shockwaves through the digital advertising world. This verdict marks a major victory for the tech giant as it battles a series of antitrust penalties levied against it in recent years. The […]
The Dutch government, led by Geert Wilders’ nationalist Freedom Party for Freedom, is pushing forward plans to introduce emergency laws aimed at severely limiting asylum and immigration into the country. The proposed laws, which would bypass the usual parliamentary procedures, have sparked heated debate both within the Netherlands and across Europe. Critics say these policies […]
The European Court of Justice (ECJ) has upheld a landmark €2.42 billion fine against Google, reinforcing a crucial precedent in the regulation of tech giants. The ruling confirms that Google’s actions to favour its own price comparison shopping service over competitors’ offerings were in violation of European Union competition law. This decision marks the end […]
In a landmark decision that could redefine the boundaries of European merger control, the Court of Justice of the European Union (CJEU) ruled in favor of Illumina Inc., a leading U.S. gene sequencing company, against the European Commission’s attempt to block its $7.1 billion re-acquisition of cancer diagnostic company Grail Inc. This ruling not only […]
Euro Manganese Inc. has officially submitted an application to secure Strategic Project status for its Chvaletice Manganese Project under the European Union’s Critical Raw Materials Act (CRMA). The CRMA, enacted in May 2024, aims to bolster the sustainable supply of raw materials deemed crucial for Europe’s economy and green transition. Key Benefits of Strategic Project […]
Astellas Pharma Inc. has announced a significant milestone in cancer treatment with the European Commission (EC’s) approval of PADCEV (enfortumab vedotin) combined with KEYTRUDA (pembrolizumab). This approval authorizes the use of this combination therapy as a first-line treatment for adult patients with unresectable or metastatic urothelial cancer who are eligible for platinum-based chemotherapy. A New […]
The European Commission (EC) has granted marketing authorisation for AKANTIOR (polihexanide), the first and only approved treatment for acanthamoeba keratitis (AK) globally, announced Avanzanite Bioscience B.V., a commercial-stage specialty pharmaceutical company. The approval, which applies to both adults and children aged 12 and over, marks a significant milestone for the treatment of this rare and […]
The European Commission has endorsed a €5 billion state aid measure for the European Semiconductor Manufacturing Company (ESMC), facilitating the establishment of a major semiconductor manufacturing plant in Dresden, Germany. This significant investment marks a pivotal step in strengthening Europe’s semiconductor production capabilities and aligns with the strategic objectives of the European Chips Act. The […]
AbbVie (NYSE: ABBV) and Genmab (NASDAQ: GMAB) have announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY (epcoritamab), a groundbreaking therapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) following two or more prior treatments. This approval marks a significant milestone as TEPKINLY becomes the first and only […]
The European Commission (EC) has granted unconditional approval for Bunge Global S.A.’s acquisition of Viterra Limited, a deal valued at approximately $34 billion. This approval, made under the EU Merger Regulation, comes with the condition that Bunge and Viterra must fully adhere to the commitments offered during the merger process. Critical Transaction Details Bunge Global […]